Dorsomorphin (Compound C): Precision AMPK Inhibitor for Experimental Innovation

Introduction: Principle and Mechanistic Overview

Dorsomorphin, also known as Compound C, stands at the forefront of targeted kinase modulation as a selective, cell-permeable, and reversible ATP-competitive AMPK inhibitor. With a Ki of 109 nM, its selectivity for AMPK over related kinases, such as protein kinase A, protein kinase C, and Janus kinase 3, makes it an indispensable tool for interrogating the AMPK signaling pathway and BMP/Smad signaling pathway. Mechanistically, Dorsomorphin blocks AMPK activity, leading to pronounced inhibition of downstream events—including up to 80% reduction in acetyl-CoA carboxylase (ACC) phosphorylation and suppression of autophagic proteolysis. In parallel, it acts as a potent BMP signaling inhibitor, interfering with phosphorylation of Smad 1/5/8 and thereby modulating differentiation and iron metabolism.

APExBIO supplies Dorsomorphin (Compound C) as a high-purity solid, ensuring batch-to-batch consistency for rigorous bench research. Researchers leverage this compound for inhibition of AMPK activity in hepatocytes, BMP4-induced SMAD phosphorylation inhibition, autophagy regulation, cancer research, iron metabolism modulation, and neural stem cell differentiation. Its robust dual-pathway activity and well-characterized solubility profile (soluble in DMSO ≥8.49 mg/mL) streamline experimental design and troubleshooting.

Step-by-Step Experimental Workflow and Protocol Enhancements

1. Compound Preparation and Storage

• Obtain Dorsomorphin (Compound C) from APExBIO to ensure reagent integrity.
• Dissolve the compound in DMSO at ≥8.49 mg/mL, using gentle warming and ultrasonic treatment for full dissolution.
• Aliquot and store solids at -20°C; prepare fresh working solutions prior to each experiment, as solutions are not recommended for long-term storage.

2. Cell-Based Assays: Inhibition of AMPK Activity and Downstream Phosphorylation

• Seed target cells (e.g., hepatocytes or HeLa cells) at appropriate density in culture plates.
• Treat with Dorsomorphin at 4–40 μM for 1–24 hours, optimizing dosage for your specific cell type and endpoint.
• Monitor AMPK inhibition via western blot (AMPK phosphorylation, ACC phosphorylation), qRT-PCR, or ELISA for downstream markers.
• Include vehicle controls (DMSO alone) and, where possible, positive controls (known AMPK activators or inhibitors).

3. BMP/Smad Pathway Modulation and Neural Induction Protocols

• For BMP4-induced SMAD phosphorylation inhibition, pre-treat cells with Dorsomorphin (IC₅₀ = 0.47 μM) prior to BMP4 stimulation.
• In neural stem cell differentiation, combine Dorsomorphin with other pathway modulators to drive efficient neural induction and self-renewal.

4. Animal Model Applications: Iron Metabolism and Inflammation

• Administer Dorsomorphin intraperitoneally at 10 mg/kg in rodent models for studies on hepatic hepcidin mRNA and serum iron modulation.
• Monitor physiological endpoints (iron levels, inflammatory markers, histopathology) to validate pathway inhibition and downstream effects.

Advanced Use-Cases and Comparative Advantages

Dissecting AMPK's Role in Macrophage Polarization and Inflammation

Recent research underscores the centrality of AMPK signaling in immunometabolic regulation, notably in obesity-related asthma. In the landmark study by Lei et al. (Inflammation, 2025), downregulation of AMPK in obese asthmatic lung tissue was tightly linked to M1 macrophage polarization and heightened airway inflammation. By employing Dorsomorphin as an ATP-competitive AMPK inhibitor, researchers can mimic the suppressed AMPK environment, enabling dissection of the JAK2/STAT3 axis and its downstream impact on inflammatory cytokine production. This approach not only models disease pathogenesis but also facilitates pharmacodynamic studies of candidate AMPK modulators.

Autophagy Regulation and Metabolic Disease Models

Dorsomorphin’s ability to suppress autophagic proteolysis and inhibit ACC phosphorylation renders it invaluable for studies on metabolic stress, cancer cell survival, and muscle atrophy. For example, "Dorsomorphin (Compound C): Precision AMPK and BMP Inhibitor" extends this application by detailing how Dorsomorphin’s robust selectivity enables clear delineation of AMPK-dependent vs. independent autophagic events, improving the interpretability of metabolic pathway studies.

Neural Stem Cell Differentiation and BMP4 Pathway Studies

In neural induction protocols, Dorsomorphin’s dual action as a BMP signaling inhibitor and AMPK modulator supports efficient conversion of human embryonic stem cells toward neural lineages. By blocking Smad 1/5/8 phosphorylation, Dorsomorphin promotes self-renewal and neural fate specification, a workflow advantage detailed in the complementary article "Dorsomorphin (Compound C): Precision AMPK Inhibitor for Translational Discovery", which benchmarks Dorsomorphin’s performance in differentiation and disease modeling.

Iron Metabolism Modulation and Hepcidin Suppression

Dorsomorphin’s capacity to reduce hepatic hepcidin gene transcription and increase serum iron offers a translational bridge between metabolic studies and iron overload or anemia models. Its specificity for the BMP/Smad axis enables researchers to precisely modulate iron homeostasis, as further substantiated by animal studies demonstrating dose-dependent reductions in hepcidin mRNA following Dorsomorphin administration.

Practical Troubleshooting & Optimization Tips

• Solubility: Dorsomorphin is insoluble in water and ethanol. Always dissolve in DMSO (≥8.49 mg/mL), applying gentle heat and ultrasonication as needed. Filter sterilize if using for cell culture.
• Stability: Avoid long-term storage of DMSO solutions; prepare fresh aliquots for each experiment to prevent degradation and loss of potency.
• Dose Optimization: For cell-based assays, titrate across 4–40 μM to identify the minimal effective concentration that achieves pathway inhibition without off-target cytotoxicity. For animal studies, start with 10 mg/kg by intraperitoneal injection and adjust based on pharmacodynamic readouts.
• Controls: Include DMSO vehicle, untreated, and pathway-activated controls (e.g., AICAR for AMPK activation) to distinguish on-target from off-target effects.
• Readout Selection: Use robust, quantitative endpoints—such as phosphorylation status (western blot), gene expression (qRT-PCR), and functional assays (iron levels, cell viability)—to validate AMPK or BMP/Smad pathway inhibition.
• Troubleshooting BMP/Smad and AMPK Dual Inhibition: If non-specific effects are observed, consider time-course studies and parallel use of selective BMP or AMPK inhibitors to parse pathway-specific contributions. The article "Dorsomorphin (Compound C): Practical Solutions for Reliable Experimental Control" provides scenario-driven troubleshooting strategies for distinguishing and leveraging Dorsomorphin’s dual activity in complex assays.

Future Outlook: Expanding the Utility of Dorsomorphin

With the intersection of metabolism, inflammation, and differentiation emerging as a nexus in disease modeling, Dorsomorphin (Compound C) is poised to remain a gold standard for pathway dissection. The ability to selectively inhibit both AMPK and BMP/Smad pathways empowers researchers to interrogate crosstalk underlying cancer, neurodegeneration, muscle atrophy, and immunometabolic disorders. Ongoing advances in omics technologies and high-content screening will further amplify Dorsomorphin’s role in phenotypic screening and drug discovery pipelines.

Future work will benefit from integrated protocols, leveraging Dorsomorphin’s dual action for multiplexed readouts and combinatorial perturbation studies. As evidenced in "Dorsomorphin (Compound C): Unveiling AMPK and BMP/Smad Signaling in Disease Modeling", the compound’s versatility in immune modulation, autophagy, and stem cell fate determination continues to drive experimental innovation across research disciplines.

Conclusion

Dorsomorphin (Compound C) from APExBIO delivers unmatched precision for researchers targeting AMPK and BMP/Smad signaling, with validated applications in inhibition of AMPK activity in hepatocytes, autophagy regulation, BMP4-induced SMAD phosphorylation inhibition, iron metabolism modulation, and neural stem cell differentiation. Its practical workflow advantages, high selectivity, and well-characterized performance profile make it a cornerstone for experimental design, troubleshooting, and translational discovery.